The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Masimo Corp

Nasdaq: MASI
Last

(U.S.) $35.19

Today's change-1.58 -4.30%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.
 

Masimo Corp

Nasdaq: MASI
Last

(U.S.) $35.19

Today's change-1.58 -4.30%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Masimo Corp crosses below 20-day moving average

Masimo Corp closed sharply lower Friday, dropping (U.S.)$1.58 or 4.30% to (U.S.)$35.19 and crossing below its 20-day moving average. Over the last five days, shares have lost 4.24% and are down 15.23% for the last year to date. This security has outperformed the S&P 500 by 39.52% during the last year.

Key company metrics

  • Open(U.S.) $36.51
  • Previous close(U.S.) $36.77
  • High(U.S.) $37.32
  • Low(U.S.) $35.14
  • Bid / Ask-- / --
  • YTD % change-15.23%
  • Volume248,607
  • Average volume (10-day)305,673
  • Average volume (1-month)409,396
  • Average volume (3-month)355,626
  • 52-week range(U.S.) $26.21 to (U.S.) $46.00
  • Beta0.91
  • Trailing P/E23.46×
  • P/E 1 year forward23.53×
  • Forward PEG2.35×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.50
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.52%

Based on its net profit margin of 12.52%, Masimo Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 03, 201510/03/2015Jul 04, 201507/04/2015Apr 04, 201504/04/2015Jan 03, 201501/03/2015
Revenue153156155162
Total other revenue--------
Total revenue153156155162
Gross profit102103103109
Total cost of revenue50535153
Total operating expense124128127129
Selling / general / administrative60626161
Research & development14131515
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income28282733
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax27272831
Income after tax18192022
Income tax, total9889
Net income19192121
Total adjustments to net income--------
Net income before extra. items19192121
Minority interest111-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items19192121
Inc. avail. to common incl. extra. items19192121
Diluted net income19192121
Dilution adjustment0------
Diluted weighted average shares54545453
Diluted EPS excluding extraordinary itemsvalue per share0.360.360.380.40
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.360.360.380.40